ArticleMediators of inflammation2025

Inhibition of SIK1 Alleviates the Pathologies of Psoriasis by Disrupting IL-17 Signaling.

Dongxuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.